Related Experiment Video
Updated: May 20, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule
Sean D Ryan1, Eric M C Britigan, Lauren M Zasadil
1Department of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, USA.
Abstract:
The mitotic checkpoint is the major cell cycle checkpoint acting during mitosis to prevent aneuploidy and chromosomal instability, which are hallmarks of tumor cells. Reduced expression of the mitotic checkpoint component Mad1 causes aneuploidy and promotes tumors in mice [Iwanaga Y, et al. (2007) Cancer Res 67:160-166]. However, the prevalence and consequences of Mad1 overexpression are currently unclear. Here we show that Mad1 is frequently overexpressed in human cancers and that Mad1 up-regulation is a marker of poor prognosis. Overexpression of Mad1 causes aneuploidy and chromosomal instability through weakening mitotic checkpoint signaling caused by mislocalization of the Mad1 binding partner Mad2. Cells overexpressing Mad1 are resistant to microtubule poisons, including currently used chemotherapeutic agents. These results suggest that levels of Mad1 must be tightly regulated to prevent aneuploidy and transformation and that Mad1 up-regulation may promote tumors and cause resistance to current therapies.
Insights
Mad1 overexpression is common in human cancers and linked to poor prognosis. Elevated Mad1 causes aneuploidy and chemoresistance, suggesting tight regulation is crucial for preventing tumors.
Area of Science:
- Cell Biology
- Cancer Research
- Genetics
Background:
- The mitotic checkpoint prevents aneuploidy and chromosomal instability, critical in cancer.
- Reduced Mad1 expression promotes tumors, but Mad1 overexpression effects are unknown.
Purpose of the Study:
- Investigate the prevalence and consequences of Mad1 overexpression in human cancers.
- Determine if Mad1 up-regulation impacts cancer prognosis and therapeutic response.
Main Methods:
- Analysis of Mad1 expression in human cancer samples.
- Cellular studies on Mad1 overexpression effects on mitotic checkpoint signaling.
- Assessing Mad1-overexpressing cells' response to chemotherapeutic agents.
Main Results:
- Mad1 is frequently overexpressed in human cancers, correlating with poor prognosis.
- Mad1 overexpression weakens mitotic checkpoint signaling by mislocalizing Mad2.
- Cells overexpressing Mad1 exhibit aneuploidy, chromosomal instability, and resistance to microtubule poisons.
Conclusions:
- Mad1 levels require strict regulation to prevent aneuploidy and transformation.
- Mad1 up-regulation may drive tumor development and confer resistance to chemotherapy.
More Related Videos
13:59Studying Mitotic Checkpoint by Illustrating Dynamic Kinetochore Protein Behavior and Chromosome Motion in Living Drosophila Syncytial Embryos
Published on: June 14, 2012
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Microtubule Instability
Microtubule Instability
Abnormal Proliferation
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Drugs that Destabilize Microtubules